Good, Bad, and Ugly

Reader reaction to Reuters news

The wrong words…

By Robert Basler
July 5, 2011
corrections | feedback | language

Roche undeterred after FDA’s Avastin rebuff

ZURICH (Reuters) – Swiss drugmaker Roche Holding AG had nothing to lose by giving Avastin another role of the dice, and by doing so showed the world it still believes the drug should be used in breast cancer.

“…another role of the dice….”

Really? Which role will the dice now play?

Helping You Help Yourselves

UK Stocks-Factors to watch on Friday July 1

LONDON, July 1 (Reuters) – Britain’s top share index is seen opening flat to lower on Friday, pausing for breath after a strong run this week, at the start of a new month and quarter, with investors focusing back on fundamentals as immediate fears over the Greek debt crisis reside.

This is a very useful site; my request is for correct spelling. the last word in this summary from your news and markets page should be ‘recede’.

Jeff

Two errors that spellcheckers wouldn’t catch, but readers would catch and did.

We corrected both: GBU Editor

A worker makes its way on a bridge at Swiss pharmaceutical company Roche plant in Basel February 2, 2011. REUTERS/Christian Hartmann

Join the Good, Bad, Ugly Facebook Blog Network’

«
»
Comments
One comment so far | RSS Comments RSS
Jul 6, 2011
8:51 am UTC

Where do I apply to become a Reuters journalist? I play scrabble regularly so I’m sure my spelling will pass muster before I even use a spellchecker.

;)

E.

Posted by egeria | Report as abusive
 

Post Your Comment

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
  •